This study explored financial conflicts of interest (FCOI) among authors of published guidelines and consensus statements and their relationship to endorsement of specific drugs. 93% of recent articles reported FCOI status. Of articles publishing funding sources, 65% reported partial or full industry funding. Endorsement of chemotherapeutic agents was strongly associated with FCOIs (p=0.001).
You are here:
Author Financial Conflicts of Interest, Industry Funding, and Clinical Practice Guidelines for Anticancer Drugs
Submitted by: Mark Ferguson
Source: Journal of Clinical Oncology
Keywords:
Author(s): Ariadna Tibau, Philippe L. Bedard, Amirrtha Srikanthan, Josee-Lyne Ethier, Francisco E. Vera-Badillo, Arnoud J. Templeton, Alberto Ocaña, Bostjan Seruga, Agustí Barnadas and Eitan Amir
